VM

Vishal Mangla

Active Director Director DIN 08832155
DIN 08832155 First appointment Jul 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value •••• Premium profile

About Vishal Mangla

Data last updated:

Vishal Mangla is a Director at Manglam Biotech Private Limited (since 2020). The company operates in Pharma. Manglam Biotech Private Limited reported revenue of ₹1.01 Cr (FY 2025).

DIN 08832155
Primary Designation Director
Industry Pharma
First Appointment 31 Jul 2020
Oldest Company Age 7 yrs
Largest company Manglam Biotech Private Limited · ₹1.01 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Manglam Biotech Private Limited U33119HR2018PTC076958
Director31 Jul 20202018₹1.01 Cr (FY 2025)Active

Board colleagues of Vishal Mangla

NameDINCompanyDesignation
Shiv Kumar Mangla01372345Manglam Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Manglam Biotech Private Limited
Premium access

Shareholding and investment profile for Vishal Mangla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vishal Mangla

Vishal Mangla currently holds 1 directorship: Manglam Biotech Private Limited (Director, since 31 Jul 2020, revenue ₹1.01 Cr (FY 2025)).

Vishal Mangla was first appointed on 31 Jul 2020 as Director at Manglam Biotech Private Limited.

The current boards of Vishal Mangla's companies include Shiv Kumar Mangla (Manglam Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available